Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
135.4 USD | -0.91% | -2.86% | +2.77% |
May. 31 | Neurocrine Biosciences Insider Sold Shares Worth $5,338,565, According to a Recent SEC Filing | MT |
May. 28 | Neurocrine Biosciences Says CEO Kevin Gorman Retiring | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NEUROCRINE BIOSCIENCES, INC. | Bio Therapeutic Drugs | -0.91% | -2.86% | +2.77% | +51.25% | +59.72% | 13.63B |
- Stock Market
- Equities
- NBIX Stock
- Charts Neurocrine Biosciences, Inc.
- Relative Strength Chart